Mri Interventions (MRIC) 1.1000 $MRIC
MRI Interventions to Report First Quarter 2014 Financial Results
GlobeNewswire - Wed Apr 30, 3:02PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today that it will release its first quarter 2014 financial results on Thursday, May 8, 2014, after the close of the U.S. financial markets. MRI Interventions will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the company's results.
Global Electrophysiology Report 2014 - The Current and Future Players
M2 - Wed Apr 30, 9:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8qjsng/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Current and Future Players" report to their offering. The report offers a comprehensive analysis of the global EP market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, UK, France, China, India, Japan and Brazil. Included within is an examination of the drivers, opportunities and barriers impacting growth of the EP market worldwide, with an in-depth breakdown of the EP market seven-year global forecast. The report identifies and evaluates key trends and unmet needs shaping the global EP market through 2020, highlighting testimonials from top physicians around the world who are utilizing these devices. Future sales expectations are discussed through careful analysis of EP use adoption patterns in the ten major markets. The report identifies and analyzes the key companies shaping and driving the Electrophysiology market. The report provides insight into the competitive Electrophysiology landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by Our team of industry experts. Scope - Investigation of current and future market competition for Electrophysiology - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using Electrophysiology in clinical practice. Key Topics Covered: 1 List of Tables 2 Introduction 3 Current and Future Players - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical 4 Pipeline Product Assessment 4.1 Pipeline Assessment by Development Stage 4.2 Segment Analysis of Pipeline Products - Ablation Catheter Pipeline Products - Diagnostic Catheter Pipeline Products 4.3 Lab Systems - Integrated X-Ray and Robotic Catheter System (Hansen Medical, Philips Healthcare) - ClearTrace System (MRI Interventions) - Robotic Catheter Guidance Lab System (North Carolina State University) - Catheter Guidance Lab System (SCR) 5 Strategic Deals Analysis 5.1 Key Acquisitions - Boston Scientific Acquires C.R. Bard's Electrophysiology Business for $275m - St. Jude Medical Acquires Endosense for $161m - Boston Scientific Acquires Rhythmia Medical for $265m 5.2 Key Partnerships - Philips and Biosense Webster Technology Integration Agreement - Biosense Webster Technology Integration Agreement with GE Healthcare Systems and Siemens Healthcare - Abbott and St. Jude Medical Broaden Alliance in US Cardiovascular Device Market 6 Appendix For more information visit http://www.researchandmarkets.com/research/8qjsng/medipoint
MRI Interventions Proudly Sponsoring 2014 Parkinson's Unity Walk
GlobeNewswire - Tue Apr 22, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced it is proud to serve as a platinum sponsor of the 2014 Parkinson's Unity Walk in New York City's Central Park on Saturday, April 26.
MRI Interventions Reports 2013 Financial Results
GlobeNewswire - Thu Mar 20, 3:00PM CDT
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its financial results for the fourth quarter and year ended December 31, 2013.
MRI Interventions Secures Commitments for $3,550,000 in Private Notes Offering
GlobeNewswire - Mon Mar 10, 7:10AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today that it has entered into a purchase agreement with certain accredited investors for a private placement of securities. Upon a closing under the purchase agreement, which is subject to satisfaction of certain closing conditions, MRI Interventions will receive gross proceeds of $3,550,000, before offering-related expenses. The securities being sold by the company consist of 12% second-priority secured non-convertible promissory notes due 2019 and warrants to purchase 0.3 share of MRI Interventions' common stock for each dollar in principal amount of notes sold by the company, such warrants having an exercise price of $1.75 per share.
MRI Interventions Welcomes Medical Device Operational Specialist Timothy T. Richards to Board of Directors
GlobeNewswire - Mon Mar 10, 7:05AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its Board of Directors has elected medical device executive Timothy T. Richards to the Board. Mr. Richards' diverse background in the medical technology industry includes over 25 years of international experience spanning the areas of operations, market and product development, and global commercial expansion.
MRI Interventions Announces Quarterly Product Revenues in Excess of $1 Million for the First Time for the Fourth Quarter of 2013
GlobeNewswire - Mon Mar 10, 7:00AM CDT
Full Year Product Revenues Exceed Guidance
MRI Interventions' ClearTrace System to be Featured in Presentation at the 2014 Western Atrial Fibrillation Symposium
GlobeNewswire - Thu Feb 27, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) announced today that its novel ClearTrace system for MRI-guided, catheter-based cardiac procedures will be featured in a presentation at the 7 Annual Western Atrial Fibrillation (AF) Symposium on Feb. 28-March 1 in Park City, Utah. The Western AF Symposium assembles a distinguished faculty of physicians and researchers from five continents to discuss the disorder, its relationship to heart failure, standards for patient care and technical advancements in the field.
MRI Interventions and Siemens Enter Into Agreement to Commercialize Next Generation Software Platform to Enable MRI-Guided, Catheter-Based Procedures
GlobeNewswire - Mon Feb 24, 7:08AM CST
MRI Interventions, Inc. (OTCQB:MRIC) and Siemens Healthcare announced today an agreement to co-develop and commercialize a next generation software platform that will enable minimally invasive catheter-based procedures to be performed under real-time magnetic resonance imaging (MRI) guidance. Today, virtually all catheter-based interventions are performed using fluoroscopy, an X-ray based imaging technique. The software platform, to be used in combination with companion MRI-guided catheters, will enable procedures to be performed under MRI guidance instead of fluoroscopic guidance. This shift to MRI-guided procedures is significant because MRI provides superior visualization of soft tissue, MRI provides continuous 3-D visualization, and MRI eliminates all radiation exposure for the patient and physician.
MRI Interventions to Present at Biotech Showcase 2014
GlobeNewswire - Thu Jan 09, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical technology company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today that Kimble Jenkins, MRI Interventions' Chief Executive Officer, will present at the 2014 Biotech Showcase in San Francisco, California on Wednesday, January 15, 2014. The presentation is scheduled to begin at 4:15 PM Pacific Time. A live webcast of the presentation will be available under the IR Calendar section of the MRI Interventions website. For those unable to listen to the live webcast, a replay will be available on MRI Interventions' website following the presentation.
MRI Interventions' ClearPoint System Utilized at Cincinnati Children's Hospital for Neurosurgical Shunt Placement
GlobeNewswire - Tue Jan 07, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that the first real-time MRI-guided neurosurgical shunt placement using the company's ClearPoint(R) Neuro Intervention System has been performed at Cincinnati Children's Hospital, representing the latest application of the platform system and illustrating its utility in a wide range of neurosurgical procedures.
MRI Interventions Adds Industry Veteran Maria Sainz as New Board Member
GlobeNewswire - Mon Jan 06, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its Board of Directors has elected veteran medical device executive Maria Sainz as its newest director. Ms. Sainz's distinguished career in the medical device industry spans over 20 years, and includes 10 years as the top executive for both emerging businesses and large corporate divisions, strong commercial experience bringing therapies to market, significant international experience, and service on both public and private company boards.
OTC Daily Alert Stock Watch - MRI Interventions, Inc. (OTCQB:MRIC)
WorldStockWire - Wed Dec 18, 4:45AM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
MRI Interventions' ClearPoint Neuro Intervention System Recently Profiled by Boston's ABC-TV Affiliate
GlobeNewswire - Mon Dec 16, 7:00AM CST
The ClearPoint Neuro Intervention System developed by MRI Interventions, Inc. (OTCQB:MRIC) was featured December 10 in a television segment and article reported by the ABC-TV affiliate in Boston (WCVB-TV).
Importance of Real-Time MRI Guidance in Delivery of Toca 511 Gene Therapy Directly to High Grade Glioma Presented at Annual Society for Neuro-Oncology Scientific Meeting
GlobeNewswire - Tue Dec 03, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced the presentation of clinical data demonstrating the precision of MRI-guided delivery of the investigational gene therapy Toca 511 to high grade gliomas using the company's ClearPoint Neuro Intervention System as the delivery platform. At the 4 Quadrennial Meeting of the World Federation of Neuro-Oncology, held in conjunction with the 18 Annual Society for Neuro-Oncology Scientific Meeting and Education Day, Dr. Manish Aghi, neurosurgeon at University of California, San Francisco (UCSF), presented a poster showing interim data from an ongoing Phase I clinical trial evaluating the safety and tolerability of Toca 511 in combination with Toca FC in recurrent high grade glioma patients.
MRI Interventions' ClearPoint System Facilitates Asleep DBS Surgery at San Francisco VA Medical Center for Veterans With Parkinson's Disease
GlobeNewswire - Tue Nov 19, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that Veterans Affairs Medical Center (VAMC) in San Francisco, California, has become the first VA hospital to offer MRI-guided asleep deep brain stimulation (DBS) surgery to veterans suffering from Parkinson's disease. Dr. Paul Larson, Chief of Neurosurgery at the San Francisco VAMC, led the center's first asleep DBS procedure on October 25, 2013, using the ClearPoint Neuro Intervention System's real-time MRI guidance and visualization to plan, target, and confirm results of the surgery, all within the hospital's diagnostic MRI suite.
MRI Interventions Announces Third Quarter 2013 Financial Results
GlobeNewswire - Tue Nov 12, 3:00PM CST
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its financial results for the quarter ended September 30, 2013.
Brain Cancer Lesion Treated with Precisely-Aimed Laser Catheter using ClearPoint Neuro Intervention System in IMRIS iMRI
CNW Group - Tue Aug 20, 7:01AM CDT
Newest joint application of two enabling medical technologies exhibits benefits of intraoperative MRI for direct visualization when navigating to treat brain tumors and neurological disorders
MRI Interventions Announces Second Quarter 2013 Financial Results
GlobeNewswire - Tue Aug 13, 3:00PM CDT
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its financial results for the quarter ended June 30, 2013.
MRI Interventions to Report First Quarter 2014 Financial Results
GlobeNewswire - Wed Apr 30, 3:02PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today that it will release its first quarter 2014 financial results on Thursday, May 8, 2014, after the close of the U.S. financial markets. MRI Interventions will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the company's results.
Global Electrophysiology Report 2014 - The Current and Future Players
M2 - Wed Apr 30, 9:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8qjsng/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Current and Future Players" report to their offering. The report offers a comprehensive analysis of the global EP market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, UK, France, China, India, Japan and Brazil. Included within is an examination of the drivers, opportunities and barriers impacting growth of the EP market worldwide, with an in-depth breakdown of the EP market seven-year global forecast. The report identifies and evaluates key trends and unmet needs shaping the global EP market through 2020, highlighting testimonials from top physicians around the world who are utilizing these devices. Future sales expectations are discussed through careful analysis of EP use adoption patterns in the ten major markets. The report identifies and analyzes the key companies shaping and driving the Electrophysiology market. The report provides insight into the competitive Electrophysiology landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by Our team of industry experts. Scope - Investigation of current and future market competition for Electrophysiology - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using Electrophysiology in clinical practice. Key Topics Covered: 1 List of Tables 2 Introduction 3 Current and Future Players - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical 4 Pipeline Product Assessment 4.1 Pipeline Assessment by Development Stage 4.2 Segment Analysis of Pipeline Products - Ablation Catheter Pipeline Products - Diagnostic Catheter Pipeline Products 4.3 Lab Systems - Integrated X-Ray and Robotic Catheter System (Hansen Medical, Philips Healthcare) - ClearTrace System (MRI Interventions) - Robotic Catheter Guidance Lab System (North Carolina State University) - Catheter Guidance Lab System (SCR) 5 Strategic Deals Analysis 5.1 Key Acquisitions - Boston Scientific Acquires C.R. Bard's Electrophysiology Business for $275m - St. Jude Medical Acquires Endosense for $161m - Boston Scientific Acquires Rhythmia Medical for $265m 5.2 Key Partnerships - Philips and Biosense Webster Technology Integration Agreement - Biosense Webster Technology Integration Agreement with GE Healthcare Systems and Siemens Healthcare - Abbott and St. Jude Medical Broaden Alliance in US Cardiovascular Device Market 6 Appendix For more information visit http://www.researchandmarkets.com/research/8qjsng/medipoint
MRI Interventions Proudly Sponsoring 2014 Parkinson's Unity Walk
GlobeNewswire - Tue Apr 22, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced it is proud to serve as a platinum sponsor of the 2014 Parkinson's Unity Walk in New York City's Central Park on Saturday, April 26.
MRI Interventions Reports 2013 Financial Results
GlobeNewswire - Thu Mar 20, 3:00PM CDT
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its financial results for the fourth quarter and year ended December 31, 2013.
MRI Interventions Secures Commitments for $3,550,000 in Private Notes Offering
GlobeNewswire - Mon Mar 10, 7:10AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today that it has entered into a purchase agreement with certain accredited investors for a private placement of securities. Upon a closing under the purchase agreement, which is subject to satisfaction of certain closing conditions, MRI Interventions will receive gross proceeds of $3,550,000, before offering-related expenses. The securities being sold by the company consist of 12% second-priority secured non-convertible promissory notes due 2019 and warrants to purchase 0.3 share of MRI Interventions' common stock for each dollar in principal amount of notes sold by the company, such warrants having an exercise price of $1.75 per share.
MRI Interventions Welcomes Medical Device Operational Specialist Timothy T. Richards to Board of Directors
GlobeNewswire - Mon Mar 10, 7:05AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its Board of Directors has elected medical device executive Timothy T. Richards to the Board. Mr. Richards' diverse background in the medical technology industry includes over 25 years of international experience spanning the areas of operations, market and product development, and global commercial expansion.
MRI Interventions Announces Quarterly Product Revenues in Excess of $1 Million for the First Time for the Fourth Quarter of 2013
GlobeNewswire - Mon Mar 10, 7:00AM CDT
Full Year Product Revenues Exceed Guidance
MRI Interventions' ClearTrace System to be Featured in Presentation at the 2014 Western Atrial Fibrillation Symposium
GlobeNewswire - Thu Feb 27, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) announced today that its novel ClearTrace system for MRI-guided, catheter-based cardiac procedures will be featured in a presentation at the 7 Annual Western Atrial Fibrillation (AF) Symposium on Feb. 28-March 1 in Park City, Utah. The Western AF Symposium assembles a distinguished faculty of physicians and researchers from five continents to discuss the disorder, its relationship to heart failure, standards for patient care and technical advancements in the field.
MRI Interventions and Siemens Enter Into Agreement to Commercialize Next Generation Software Platform to Enable MRI-Guided, Catheter-Based Procedures
GlobeNewswire - Mon Feb 24, 7:08AM CST
MRI Interventions, Inc. (OTCQB:MRIC) and Siemens Healthcare announced today an agreement to co-develop and commercialize a next generation software platform that will enable minimally invasive catheter-based procedures to be performed under real-time magnetic resonance imaging (MRI) guidance. Today, virtually all catheter-based interventions are performed using fluoroscopy, an X-ray based imaging technique. The software platform, to be used in combination with companion MRI-guided catheters, will enable procedures to be performed under MRI guidance instead of fluoroscopic guidance. This shift to MRI-guided procedures is significant because MRI provides superior visualization of soft tissue, MRI provides continuous 3-D visualization, and MRI eliminates all radiation exposure for the patient and physician.
MRI Interventions to Present at Biotech Showcase 2014
GlobeNewswire - Thu Jan 09, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical technology company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today that Kimble Jenkins, MRI Interventions' Chief Executive Officer, will present at the 2014 Biotech Showcase in San Francisco, California on Wednesday, January 15, 2014. The presentation is scheduled to begin at 4:15 PM Pacific Time. A live webcast of the presentation will be available under the IR Calendar section of the MRI Interventions website. For those unable to listen to the live webcast, a replay will be available on MRI Interventions' website following the presentation.
MRI Interventions' ClearPoint System Utilized at Cincinnati Children's Hospital for Neurosurgical Shunt Placement
GlobeNewswire - Tue Jan 07, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that the first real-time MRI-guided neurosurgical shunt placement using the company's ClearPoint(R) Neuro Intervention System has been performed at Cincinnati Children's Hospital, representing the latest application of the platform system and illustrating its utility in a wide range of neurosurgical procedures.
MRI Interventions Adds Industry Veteran Maria Sainz as New Board Member
GlobeNewswire - Mon Jan 06, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its Board of Directors has elected veteran medical device executive Maria Sainz as its newest director. Ms. Sainz's distinguished career in the medical device industry spans over 20 years, and includes 10 years as the top executive for both emerging businesses and large corporate divisions, strong commercial experience bringing therapies to market, significant international experience, and service on both public and private company boards.
OTC Daily Alert Stock Watch - MRI Interventions, Inc. (OTCQB:MRIC)
WorldStockWire - Wed Dec 18, 4:45AM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
MRI Interventions' ClearPoint Neuro Intervention System Recently Profiled by Boston's ABC-TV Affiliate
GlobeNewswire - Mon Dec 16, 7:00AM CST
The ClearPoint Neuro Intervention System developed by MRI Interventions, Inc. (OTCQB:MRIC) was featured December 10 in a television segment and article reported by the ABC-TV affiliate in Boston (WCVB-TV).
Importance of Real-Time MRI Guidance in Delivery of Toca 511 Gene Therapy Directly to High Grade Glioma Presented at Annual Society for Neuro-Oncology Scientific Meeting
GlobeNewswire - Tue Dec 03, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced the presentation of clinical data demonstrating the precision of MRI-guided delivery of the investigational gene therapy Toca 511 to high grade gliomas using the company's ClearPoint Neuro Intervention System as the delivery platform. At the 4 Quadrennial Meeting of the World Federation of Neuro-Oncology, held in conjunction with the 18 Annual Society for Neuro-Oncology Scientific Meeting and Education Day, Dr. Manish Aghi, neurosurgeon at University of California, San Francisco (UCSF), presented a poster showing interim data from an ongoing Phase I clinical trial evaluating the safety and tolerability of Toca 511 in combination with Toca FC in recurrent high grade glioma patients.
MRI Interventions' ClearPoint System Facilitates Asleep DBS Surgery at San Francisco VA Medical Center for Veterans With Parkinson's Disease
GlobeNewswire - Tue Nov 19, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that Veterans Affairs Medical Center (VAMC) in San Francisco, California, has become the first VA hospital to offer MRI-guided asleep deep brain stimulation (DBS) surgery to veterans suffering from Parkinson's disease. Dr. Paul Larson, Chief of Neurosurgery at the San Francisco VAMC, led the center's first asleep DBS procedure on October 25, 2013, using the ClearPoint Neuro Intervention System's real-time MRI guidance and visualization to plan, target, and confirm results of the surgery, all within the hospital's diagnostic MRI suite.
MRI Interventions Announces Third Quarter 2013 Financial Results
GlobeNewswire - Tue Nov 12, 3:00PM CST
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its financial results for the quarter ended September 30, 2013.
Brain Cancer Lesion Treated with Precisely-Aimed Laser Catheter using ClearPoint Neuro Intervention System in IMRIS iMRI
CNW Group - Tue Aug 20, 7:01AM CDT
Newest joint application of two enabling medical technologies exhibits benefits of intraoperative MRI for direct visualization when navigating to treat brain tumors and neurological disorders
MRI Interventions Announces Second Quarter 2013 Financial Results
GlobeNewswire - Tue Aug 13, 3:00PM CDT
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its financial results for the quarter ended June 30, 2013.
